Precision medicines to match the complexity of the human brain. Backed by Third Rock Ventures.
About the role
In this high-visibility role, you will support patient safety across all clinical development programs, including early and late phase development. As an accomplished signal detection and safety surveillance leader with a forward thinking, technology enabled mindset, you will lead safety strategy and risk management supported by scientifically robust data sources including clinical trials, real-world data, literature, preclinical findings, and other relevant data sources and guide the team in evaluating and... Found on 1752vc Careers, the job board for startup and VC roles.
What they're looking for
- Demonstrated ability to lead and influence in a matrix environment
- Experience with interacting and leading with Regulatory Authorities (i.e. FDA, EMA) at type C, B, pre-BLA/MAA meetings, Advisory Committee meetings, or other scientific advice forums
- Strong analytical and strategic thinking, problem-solving, and decision-making skills
- Strong organizational and time management skills, with the ability to prioritize and manage multiple tasks effectively
- Strong interpersonal and communication (written and verbal) skills
More about this role
When our people share why they joined Rapport and love it here, it comes down to three things: the science, the mission, and the team. At Rapport, we’re driven by a passion for developing precision neuromedicines with the potential for fewer side effects, enabling patients and their families to enjoy healthier, more fulfilling lives. And we’re doing this with extraordinary science and awesome people (affectionately called Rapptors).
Our innovative scientific platform is centered on Receptor Associate Proteins (RAPs). RAPs are a component of neuronal receptor complexes, which play a crucial role in regulating receptor assembly and function. This precision approach has the potential to revolutionize the development of small molecule therapies. We are excited about the potential of our lead program, RAP-219. Our first indication targets focal epilepsy with additional clinical trials in primary generalized tonic-clonic seizures (PGTCS) and bipolar disorder.
The strength of Rapport comes from our Rapptors – who are united by our mission to improve patients lives. We bring the heart and hustle to advance our science forward, always staying true to our core values. We hope you’re as...
Browse similar: Startup jobs